Matinas BioPharma Holdings (MTNB) Gains (Losses) on Sale of Assets & Investments (2019 - 2026)
Matinas BioPharma Holdings (MTNB) reported Non Operating Investment Income of -$138,000 for Q2 2026, compared with $110,000 a year earlier.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Gains (Losses) on Sale of Assets & Investments (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Matinas BioPharma Holdings' Non Operating Investment Income came in at -$101,000; for FY2025, it came in at $37,000.
- Non Operating Investment Income has a five-year compound annual growth rate of -49.0% (FY2020 to FY2025).
- By year, Non Operating Investment Income came in at $484,000 in FY2023 (-86.1%), $3.49 million in FY2022 (+162.9%) and $1.33 million in FY2021 (+23.7%).
- The Q2 2026 figure ranks as the lowest quarterly Non Operating Investment Income in data going back to Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Matinas BioPharma Holdings | 508,224.03 | -12.08 Mn | - | -138,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -138,000.00 |
| Dec 31, 2025 | -73,000.00 |
| Jun 30, 2025 | 110,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 83,000.00 |
| Mar 31, 2024 | 87,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Sep 30, 2023 | 155,000.00 |
| Jun 30, 2023 | 81,000.00 |
| Mar 31, 2023 | 229,000.00 |
| Dec 31, 2022 | 1.76 Mn |
| Mar 31, 2022 | 1.73 Mn |
| Dec 31, 2021 | -470.00 |
| Mar 31, 2021 | 1.33 Mn |
| Mar 31, 2020 | 1.07 Mn |
| Jun 30, 2019 | 1.01 Mn |
API Access
Matinas BioPharma Holdings Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();